A multicenter retrospective study, conducted in China between January 2009 and December 2022, identified 24 cases of SM with AML1::ETO + AML across 16 centers, as well as 212 cases of AML1::ETO-positive AML harboring KIT mutations during the same period (6). Here, RUNX1 is linked to systemic mastocytosis.